Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  C.R. Bard    BCR

C.R. BARD (BCR)
Mes dernières consult.
Most popular
  Report  
 SummaryQuotesNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Financials (USD)
More Financials
Company
C.R. Bard, Inc. designs, develops, manufactures, distributes and markets medical technologies in the fields of vascular, urology, oncology and surgical specialty products.It sells products to hospitals, individual healthcare professionals, extended care facilities and alternate site facilities.The... 
More about the company
Latest news on C.R. BARD
01/02BECTON DICKINSON AND : BD Completes Bard Acquisition, Creating New Global Health..
AQ
01/01BECTON, DICKINSON AND COMPANY (NYSE : BDX) Files An 8-K Other Events
AQ
2017BARD C R INC /NJ/ : Entry into a Material Definitive Agreement, Termination of a..
AQ
2017C R BARD : BD Completes Bard Acquisition, Creating New Global Health Care Leader
PR
2017BECTON DICKINSON AND : and C. R. Bard; Analysis To Aid Public Comment
AQ
2017C R BARD : BD Statement On MOFCOM Clearance Of Bard Acquisition
PR
2017BECTON DICKINSON AND : FTC Requires Divestiture of Two Medical Device Product Li..
AQ
2017C R BARD : BD Statement On FTC Clearance Of Bard Acquisition
PR
2017C R BARD : Researchers Submit Patent Application, "Implantable Prosthesis for So..
AQ
2017BECTON DICKINSON AND : U.S. Patents Awarded to Inventors in Utah (Dec. 15)
AQ
More news
Sector news : Medical Equipment, Supplies & Distribution - NEC
04/19China May Request Minor Restrictions for Essilor Merger, Says Luxottica Chair..
DJ
04/19LUXOTTICA : chairman says China may seek 'minor restrictions' to clear Essilor d..
RE
04/04Smith & Nephew picks new CEO who sold his last company
RE
03/12Sensirion, Medartis to raise cash in Swiss IPO boom
RE
03/12STRAUMANN : Medartis to use IPO proceeds to expand amid rising implant demand
RE
More sector news : Medical Equipment, Supplies & Distribution - NEC
4-Traders Strategies on C.R. BARD 
C.R. BARD - 2013
Still an upward potential
BUY
More Strategies
News from SeekingAlpha
01/23Fundsmith Annual Letter To Shareholders 2017 
01/08Dividend Income Update December 2017 
2017Dividend Champions For January 2018 (Part 1) 
2017Huntington Ingalls set to join S&P 500 
2017FTC conditionally signs off on BD's takeover of Bard 
Chart C.R. BARD
Duration : Period :
C.R. Bard Technical Analysis Chart | BCR | US0673831097 | 4-Traders
Income Statement Evolution
Consensus
 
Mean consensus
Number of Analysts
Average target price -
Spread / Average Target
EPS Revisions
Managers
NameTitle
Timothy M. Ring Chief Executive Officer
Christopher S. Holland Chief Financial Officer & Senior Vice President
John A. DeFord Senior VP-Science, Technology & Clinical Affairs
Patricia G. Christian VP-Quality, Regulatory & Medical Affairs
Patrick D. Roche Vice President-Information Technology Solutions
Sector and Competitors
1st jan.Capitalization (M$)
C.R. BARD0.00%0
MEDTRONIC PLC-1.05%108 294
BAXTER INTERNATIONAL3.73%36 060
ZIMMER BIOMET HOLDINGS-8.58%22 415
TERUMO CORP10.59%21 605
HOYA CORPORATION-0.61%20 235